Professor Dror Harats, M.D., CEO of VBL Therapeutics, describes Phase III clinical trials of a cancer treatment in which a virus is injected intravenously and cuts off blood supply to solid tumors, shrinking cancerous growths.
-
Eliyahu Tulshinski in Israeli Innovation & TechnologyPosted on FacebookPosted on UWIPosted on UWJVideos
WATCH: Israeli drug doubles survival time for patients with brain tumors
Pineal Tumor (Wikipedia)
brain tumorscancer treatmentDror Haratssolid tumorsVBL Therapeuticsvirus
Related Post
-
WATCH: IDF kills nine terrorists in counterterror raids in Jenin
IDF troops also confiscated dozens of weapons, shut down four IED-making labs, and eliminated a…
-
WATCH: Israel’s oldest citizen turns 110
Tzila Cohen immigrated to pre-state Israel in 1936 and helped lay the cornerstone for Netanya's…
-
WATCH: Holocaust survivor teaches pro-Palestinian supporters what a genocide really is
Sami, a Holocaust survivor along with comedian Zach Sage, spoke with several pro-Palestinian or even…